Actively Recruiting
Clinical Registration Study of Patients With Intracranial / Carotid Stenosis
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2023-04-18
500
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting data from patients aged 40 and older who have significant narrowing (stenosis) of the intracranial or carotid arteries to study how this condition relates to cognitive impairment. The study aims to analyze clinical information, brain imaging, and neuropsychological test results to identify early signs of cognitive decline in these patients. This is an observational registration study supported by the Second Affiliated Hospital, School of Medicine, Zhejiang University. Participants will receive standard medical treatment and may undergo interventional stenting as part of their care, though the study mainly observes and collects data without assigning specific treatments. Data collection includes clinical assessments and various brain imaging techniques. The study follows patients prospectively to monitor changes over time. During the study, participants will undergo cognitive testing using several scales such as the Mini-mental State Examination, Montreal Cognitive Assessment, Colour Trail Test, Hopkins Verbal Learning Test, clock drawing test, Animal Fluency Test, and Olfactory stick test. Researchers will also assess cerebral blood flow, glymphatic function, stroke incidence, and metabolic changes over a two-year follow-up period. Participants will be monitored regularly to track these outcomes and any safety concerns.
CONDITIONS
Brief Title
Clinical Registration Study of Patients With Intracranial / Carotid Stenosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 40 years or older
- At least 50% stenosis in one side of the intracranial or carotid artery
- Written informed consent provided
You will not qualify if you...
- Previous major head trauma or any brain surgery
- Brain abnormalities such as hemorrhage or space-occupying lesions
- Movement disorders or mental illness affecting cognitive testing
- Severe loss of vision, hearing, or ability to communicate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 years
Participants are observed while receiving standard medical treatment or interventional stenting as part of their clinical care.
Regular visits to assess cognitive and neurological function over 2 years
Trial Site Locations
Total: 1 location
1
Second Affilated Hospital of Zhejiang University, School of Medicine
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
M
Min Lou, PhD, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0